Advancing Guideline-Directed Care in Hypertrophic Cardiomyopathy
Advancing Guideline-Directed Care in Hypertrophic Cardiomyopathy is organized by Heart Rhythm Society (HRS).
Expires on: 12/15/2024
Target Audience:
This activity is intended for all those who study and treat heart rhythm disorders.
Description:
Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for identifying predisposition for genetic heart disease and sudden death, which can be lifesaving for some patients, the Heart Rhythm Society developed a webinar to increase awareness and adoption of guideline directed care for the diagnosis and treatment of patients with hypertrophic cardiomyopathy (HCM).
Learning Objectives:
• Describe the growing role of genetic testing in clinical practice for patients with HCM.
• Discuss how genetic testing fits in to multidisciplinary care of the patient with HCM.
• Discuss barriers to referral for genetic testing and possible solutions